Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 6 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| COMBINATORX, INC | 181,388 | reported | 27 Feb 2016 | tx 23+1,184,007−66,911 |
| Zura Bio Ltd | 51,000 | reported | 21 May 2025 | tx 6+1,735,135 |
| Inhibikase Therapeutics, Inc. | 38,176 | reported | 21 Feb 2026 | tx 7+763,626−19,089 |
| Ruthigen, Inc. | 15,000 | reported | 28 Jan 2021 | tx 6+187,800 |
| Arcutis Biotherapeutics, Inc. | 6,177 | reported | 04 Dec 2025 | tx 3+24,700 |
| Galecto, Inc. | 720 | reported | 18 Jun 2025 | tx 8+170,544−1,844 |
| ARENA PHARMACEUTICALS INC | 0 | reported | 11 Mar 2022 | tx 78+7,689,722−2,288,997 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 Feb 2026 | OTHER | Inhibikase Therapeutics, Inc. | 19,089 | 0.00 USD | |
| 04 Dec 2025 | GRANT_AWARD | Arcutis Biotherapeutics, Inc. | 2,021 | 0.00 USD | |
| 04 Dec 2025 | GRANT_AWARD | Arcutis Biotherapeutics, Inc. | 6,177 | 0.00 USD | deriv |
| 04 Dec 2025 | GRANT_AWARD | Arcutis Biotherapeutics, Inc. | 16,502 | 0.00 USD | deriv |
| 21 Feb 2025 | GRANT_AWARD | Inhibikase Therapeutics, Inc. | 57,265 | 0.00 USD | |
| 30 Jun 2025 | GRANT_AWARD | Inhibikase Therapeutics, Inc. | 108,176 | 0.00 USD | deriv |
| 18 Jun 2025 | GRANT_AWARD | Galecto, Inc. | 720 | 0.00 USD | deriv |
| 21 May 2025 | GRANT_AWARD | Zura Bio Ltd | 51,000 | 0.00 USD | deriv |
| 14 Feb 2025 | GRANT_AWARD | Inhibikase Therapeutics, Inc. | 116,585 | 0.00 USD | deriv |
| 14 Feb 2025 | GRANT_AWARD | Inhibikase Therapeutics, Inc. | 56,600 | 0.00 USD | deriv |
| 09 Dec 2024 | GRANT_AWARD | Zura Bio Ltd | 117,000 | 0.00 USD | deriv |
| 21 Oct 2024 | PURCHASE | Inhibikase Therapeutics, Inc. | 365,000 | 1.37 USD | anomaly |
| 21 Oct 2024 | GRANT_AWARD | Inhibikase Therapeutics, Inc. | 60,000 | 0.00 USD | deriv |
| 20 Jun 2024 | GRANT_AWARD | Galecto, Inc. | 18,000 | 0.00 USD | deriv |
| 22 Apr 2024 | PURCHASE | Zura Bio Ltd | 159,744 | 3.13 USD | anomaly |
| 14 Jun 2023 | GRANT_AWARD | Galecto, Inc. | 18,000 | 0.00 USD | deriv |
| 05 Jun 2023 | PURCHASE | Zura Bio Ltd | 117,647 | 4.25 USD | first after silenceanomaly |
| 01 Jun 2023 | GRANT_AWARD | Zura Bio Ltd | 1,130,000 | 0.00 USD | deriv |
| 14 Jun 2022 | GRANT_AWARD | Galecto, Inc. | 18,000 | 0.00 USD | deriv |
| 11 Mar 2022 | OTHER | ARENA PHARMACEUTICALS INC | 28,800 | — | |
| 11 Mar 2022 | OTHER | ARENA PHARMACEUTICALS INC | 85,847 | — | |
| 11 Mar 2022 | OTHER | ARENA PHARMACEUTICALS INC | 250 | — | |
| 08 Mar 2022 | GIFT | ARENA PHARMACEUTICALS INC | 10,500 | 98.51 USD | |
| 11 Mar 2022 | OTHER | ARENA PHARMACEUTICALS INC | 138,139 | — | deriv |
| 11 Mar 2022 | OTHER | ARENA PHARMACEUTICALS INC | 56,861 | — | deriv |
3 purchases reported after at least 12 months of silence — most recent on 05 Jun 2023.